Aller au contenu principal
Accès ouvert déclaré 2025 review

Therapeutic Outcomes of Graduated and Progressive Compression in Chronic Venous Disorders: A Meta-Analysis

0Citations signalées, ce qui n’est pas une note de qualité
11Institutions déclarées
4Pays d’affiliation déclarés

Rattachement africain : sa, gb, Soudan, ie. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Chronic venous disorders (CVD) are a common health problem affecting millions of people worldwide. Compression therapy, including graduated compression (graduated elastic compression stockings (GECS)) and progressive compression (progressive elastic compression stockings (PECS)), is a widely used treatment for CVD. This meta-analysis aimed to determine whether PECS provides superior clinical and hemodynamic outcomes compared to GECS in patients with CVDs. Clinical efficacy was defined as the disappearance or significant improvement in the sensation of fatigue or heaviness as reported by patients or assessed through validated symptom scales. A systematic literature search was conducted in PubMed, EMBASE, and Cochrane databases to identify randomized controlled trials (RCTs) comparing GECS and PECS for CVD from inception to November 23, 2024. The primary outcomes were clinical improvement, interface pressure, and ejection fraction. Secondary outcomes included tightness, ease of donning, and adverse events. Data were pooled using a random-effects meta-analysis model, with odds ratios (ORs) and mean differences (MDs) calculated along with 95% confidence intervals (CIs). Five RCTs involving 874 patients were included in the meta-analysis. PECS demonstrated significantly higher clinical improvement rates compared to GECS. Additionally, PECS resulted in a significantly higher interface pressure at level C (calf level), which is crucial for optimal venous hemodynamics. However, no significant difference was found between the two modalities in terms of improving ejection fraction. Secondary outcomes, such as tightness and ease of donning, showed no significant differences between the two groups. This meta-analysis suggests that PECS may be a more effective treatment option for CVD compared to GECS. However, further high-quality RCTs with longer follow-up periods are needed to confirm these findings and to assess the long-term benefits of PECS.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Therapeutic Outcomes of Graduated and Progressive Compression in Chronic Venous Disorders: A Meta-Analysis
Date Crossref
05/11/2025
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Diagnosis and Treatment of Venous DiseasesVenous Thromboembolism Diagnosis and ManagementDermatologic Treatments and Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.